Gharbia, S., Balta, C., Herman, H., Rosu, M., Váradi, J., Bácskay, I., . . . Hermenean, A. (2018). Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis. Front Pharmacol.
Citación estilo ChicagoGharbia, Sami, et al. "Enhancement of Silymarin Anti-fibrotic Effects By Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis." Front Pharmacol 2018.
Cita MLAGharbia, Sami, et al. "Enhancement of Silymarin Anti-fibrotic Effects By Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis." Front Pharmacol 2018.